Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03547180 · ClinicalTrials.gov registry record · NA
Mechanisms of Treatment Change in Panic Disorder and Agoraphobia
A NA study of Panic Disorder With Agoraphobia, sponsored by Southern Methodist University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT03547180: Completed NA study of Panic Disorder With Agoraphobia, sponsored by Southern Methodist University.
NCT03547180 is a NA study of Panic Disorder With Agoraphobia that has completed, run by Southern Methodist University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03547180, a NA study of Panic Disorder With Agoraphobia, has completed, sponsored by Southern Methodist University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of the present study is to identify mechanisms of therapeutic change of two theoretically contrasting therapeutic procedures: The first phase consists of comparing the outcome of the capnometry-assisted breathing therapy (BRT) with cognitive restructuring (CT). During the second phase participants of both interventions will undergo in-vivo exposure.
Primary Outcome
Clinician administered; 7 items rated on 0 - 4 scale; scores over 9 suggest the need for formal diagnostic assessment
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Therapy
- BEHAVIORAL Capnometry-Assisted Respiratory Training
- BEHAVIORAL In-vivo exposure
Study Locations (1)
Texas
- Southern Methodist University, Department of Psychology - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2004-01 |
| Est. Completion | 2008-03 |
| Phase | NA |
What the finished NCT03547180 record still lists
NCT03547180 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Panic Disorder With Agoraphobia appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Therapy is the first listed.
NCT03547180 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03547180 about?
NCT03547180 is a clinical study titled "Mechanisms of Treatment Change in Panic Disorder and Agoraphobia". The primary goal of the present study is to identify mechanisms of therapeutic change of two theoretically contrasting therapeutic procedures: The first phase consists of comparing the outcome of the capnometry-assisted breathing therapy (BRT) with cognitive restructuring (CT). During the second pha...
What is the current status of trial NCT03547180?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2004-01. Estimated completion is 2008-03.
What conditions does trial NCT03547180 study?
This clinical trial studies the following conditions: Panic Disorder With Agoraphobia.
What interventions are being tested in trial NCT03547180?
The interventions under investigation include: Cognitive Therapy (BEHAVIORAL), Capnometry-Assisted Respiratory Training (BEHAVIORAL), In-vivo exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT03547180?
This trial is sponsored by Southern Methodist University, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03547180 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Panic Disorder With Agoraphobia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03547180's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia